Prohibited Versus Restricted: Two Different Doors
"Can this page carry Google-served ads?" splits at the first branch. Prohibited content falls under Google publisher content policies: Google states it does not allow ads on content with those characteristics, and violations can lead to corrective action on the account. Restricted content falls under Google publisher restrictions: AdSense code may still be placed, but fewer ad sources bid, and Google Ads does not serve on content carrying a restriction label.
| Content category | Can Google-served ads appear? | Expected ad volume | Policy example (as listed by Google) |
|---|
| Prohibited content policies (harmful health claims, misleading statements) | No — Google disallows ads; violations can trigger account action | None | Anti-vaccination advocacy; denying AIDS or COVID-19; conversion therapy; impersonating Google products |
| Restricted content categories (prescription drugs, unapproved supplements) | Partly — AdSense code may be placed, but Google Ads will not serve | Likely lower; fewer ad sources bid | Online pharmacy; ephedrine products; supplements with active pharmaceutical or hazardous ingredients |
The third column carries the planning consequence. Restricted content is not banned; it earns fewer bidders and loses Google Ads demand, so budget expectations change rather than eligibility. Prohibited content has no ad path at all, which makes rewriting unavoidable.
Where Diabetes-Program Copy Becomes Policy-Exposed
Three claim buckets carry most of the risk on this page type.
Harmful health claims. The test is not whether copy sounds optimistic. The policy bars content that promotes harmful health claims, or that concerns a current major health crisis in a way contradicting authoritative scientific consensus; Google's examples are anti-vaccination advocacy, denial that AIDS or COVID-19 exist, and sexual-orientation conversion therapy. Diabetes copy rarely hits these head-on, but adjacent claims can: framing standard care as a conspiracy, dismissing a diagnosis as nonexistent, or telling readers to abandon authoritative guidance. That is a prohibited door, not a volume problem.
Misleading statements. Google bars content that misrepresents, falsifies, or hides information about the publisher, the creator, the content's purpose, or the content itself, and content that falsely implies a relationship with or endorsement by another person, organization, product, or service — its example is impersonating Google products or misusing company logos. The failure pattern on diabetes pages is structural: a lead-gen site styled like a health system, a clinic mark repeated without permission, "recommended by your doctor" with no basis, or a program implying government sponsorship it lacks. Test: can a reader tell who runs the page, what the program is, and whether any named body endorsed it?
Drug and supplement promotion. Selling prescription drugs online and promoting unapproved drugs and supplements are restricted categories. Examples include sales of prescription drugs, online pharmacies, ephedrine-containing products, herbal or dietary supplements with active pharmaceutical or hazardous ingredients, and names confusingly similar to unapproved drugs, supplements, or controlled substances. A page that upsells a supplement stack or routes readers to a prescription purchase lands here — monetizable, but thinner.
When Traffic Promises Become the Violation
If the page displays related-search or product-integrated-feature (PIF) units, the promise in the ad that brought the visitor in is reviewed alongside the landing page. Traffic sources must be relevant to and accurately describe the target page, may not promise products, services, or promotions absent or hard to find there, and you own every source, including affiliates and ad networks.
Google's penalty model splits by promise quality. Vague or non-explicit promises are normal violations, and five normal violations equal one strike; Google's example involves promising a list of top doctors nearby without supplying a real list. Concrete promises you cannot fulfill are egregious, one strike each: free or cash offers, promised loans, promised admission, unreasonably cheap offers, promises outside your control, and identity misrepresentation. On diabetes pages the realistic egregious patterns are a "free" program gated behind undisclosed conditions, a cash-incentive headline the page never honors, and a clinical-sounding brand implying a provider relationship it does not have.
Layout Choices That Decide Eligibility
Compliant copy can still fail on placement.
- Focal point. If the related-search or PIF unit is the page's obvious focus — no other visible content, content fully obscured, or content revealed only after user action — that is egregious.
- Accidental clicks. "Search now for the best offer," "click here," arrows, or other objects directing clicks are normal violations.
- Parity. Ads must not outnumber organic results; more ads than organic results is normal, while no organic results or wholly irrelevant ones is egregious.
- Labeling and caps. Ads must be clearly identified, distinct from results, and shown alongside results rather than as results; no incentives to search or view ads; at most two AdSense search ad boxes per page, on search results pages only.
- Adjacent screens. No Google-served ads on pages violating web-search spam policies, on misleading experiences, or alongside malware or unwanted software.
Pre-Launch Self-Check and Evidence Limits
Run five checks before the page goes live:
- Does any copy contradict authoritative scientific consensus or deny that a condition exists?
- Can a reader identify who operates the page, what the program is, and whether anyone endorsed it?
- Does the page sell, link to, or upsell prescription drugs or unapproved supplements?
- Does each traffic source's promise match what the landing page actually delivers, affiliate creative included?
- Is every search or related-search unit clearly labeled, secondary to real content, and free of click-directing cues?
Four limits belong with this checklist. All policy wording here was retrieved from Chinese-language versions of Google Help Center pages, so confirm the English wording before quoting verbatim. Google has published no diabetes-specific guidance in the retrieved material, so this applies general categories by extension. Enforcement, strike counts, and account actions are Google's discretion and are not predictable from policy text; restricted content means fewer ads, not a ban. Questions about program design, eligibility, coverage, or outcomes need program-owner, government, or clinician sources, not this page.
研究の知恵